| Property | Value |
|---|
|
?:abstract
|
-
Severe Acute Respiratory Syndrome corona virus 2 (SARS CoV-2) is a positive single stranded RNA virus, it causes respiratory failure in human and its infection is referred to as COVID 19 (Coronavirus disease 2019) COVID 19 is recognized as pandemic SARS CoV-2 likely uses angiotensin converting enzymes-2 (ACE-2) as entry receptor which is different from SARS CoV-1 and highly expressed in lungs followed by heart and gastrointestinal tract This virus is primarily transmitted through droplets and fomites in contact and is responsible for formation of more mucus in both lungs and causes death As per WHO guidelines, different testing strategies are needed for rapid identification of COVID 19 positive patients at national level within the country Countries having no such testing facility can send the viral specimen to the WHO reference laboratories Multiplex real time RT-PCR, serological test, interferon can be used for the diagnosis of this viral infection Anti-malaria drug i e hydroxychloroquine is quite effective during the treatment of COVID 19 patients So the demand of this drug increases suddenly Different institutions are also now trying to control this viral infection through gene targeting Till date, there is no vaccine against this infection and the best solution to control the spread of COVID 19 is prevention which includes social distancing, hand hygiene, use of standardized masks etc
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
Research_Journal_of_Biotechnology
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Review Paper: SARS CoV-2: A recently known global catastrophic virus
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}